Sui Yi, Chen Wenhuo, Chen Chushuang, Chang Yanting, Bivard Andrew, Wang Peng, Geng Yu, Parsons Mark, Lin Longting
Department of Neurology, Shenyang First People's Hospital, Shenyang Medical College Affiliated Brain Hospital, Shenyang Clinical Research Center for Neurological Diseases, China (Y.S.).
Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, China (Y.S.).
Stroke. 2024 May;55(5):1227-1234. doi: 10.1161/STROKEAHA.123.045091. Epub 2024 Mar 15.
Recent trials confirmed the effectiveness of endovascular therapy in patients with large ischemic cores. Yet the optimal neuroimaging modalities to define large core remains unclear. We tried to address this question by comparing the functional outcomes in patients receiving thrombectomy selected by either noncontrast computed tomography Alberta Stroke Program Early Computed Tomography Score (ASPECTS) or computed tomography perfusion (CTP).
This study retrospectively selected patients enrolled in the International Stroke Perfusion Registry between August 2011 and April 2022. Patients with acute stroke with large vessel occlusion in anterior circulation treated with endovascular therapy were included. All received both CTP and noncontrast computed tomography. The primary outcome was defined as poor functional outcome represented by a modified Rankin Scale score of 5 to 6 at 3 months. Large cores were defined in terms of either (1) noncontrast computed tomography ASPECTS ≤5 or (2) core volume ≥70 mL on CTP.
A total of 1115 patients were included in the analysis, of which 90 patients had ASPECTS ≤5 (8.1%) and 97 patients CTP core ≥70 mL (8.7%). A fair agreement between ASPECTS and CTP with a κ value of 0.31 (0.21-0.40) was found. Compared with patients with neither CTP nor ASPECTS large cores, those with only ASPECTS-defined large cores (ie, ASPECTS ≤5; n=56) did not have a higher adjusted odds of poor outcome (29%; odds ratio, 1.84 [0.91-3.73]; =0.089). However, patients with CTP large core but not ASPECTS-defined large core (n=63) had a higher adjusted odds of poor outcome (60%; odds ratio, 3.91 [2.01-7.60]; <0.001). In time-stratified subgroup analysis (>6 versus ≤6 hours), ASPECTS showed no discriminative difference between ≤5 and >5 in poor outcome for patients receiving endovascular therapy within 6 hours.
CTP core ≥70 mL-defined large cores are more predictive of poor outcome than ASPECTS ≤5-defined core in endovascular therapy patients, particularly within 6 hours after stroke onset.
近期试验证实了血管内治疗对具有大面积缺血核心的患者的有效性。然而,用于定义大面积核心的最佳神经影像学方法仍不明确。我们试图通过比较接受取栓治疗的患者(根据非增强计算机断层扫描阿尔伯塔卒中项目早期计算机断层扫描评分(ASPECTS)或计算机断层扫描灌注(CTP)进行选择)的功能结局来解决这个问题。
本研究回顾性选取了2011年8月至2022年4月期间纳入国际卒中灌注登记处的患者。纳入接受血管内治疗的急性前循环大血管闭塞性卒中患者。所有患者均接受了CTP和非增强计算机断层扫描。主要结局定义为3个月时改良Rankin量表评分为5至6所代表的功能结局不良。大面积核心根据以下两种情况定义:(1)非增强计算机断层扫描ASPECTS≤5或(2)CTP上的核心体积≥70 mL。
共有1115例患者纳入分析,其中90例患者ASPECTS≤5(8.1%),97例患者CTP核心≥70 mL(8.7%)。发现ASPECTS与CTP之间存在中等程度的一致性,κ值为0.31(0.21 - 0.40)。与既无CTP也无ASPECTS大面积核心的患者相比,仅具有ASPECTS定义的大面积核心(即ASPECTS≤5;n = 56)的患者不良结局的校正比值并未升高(29%;比值比,1.84 [0.91 - 3.73];P = 0.089)。然而,具有CTP大面积核心但无ASPECTS定义的大面积核心(n = 63)的患者不良结局的校正比值更高(60%;比值比,3.91 [2.01 - 7.60];P < 0.001)。在时间分层亚组分析(>6小时与≤6小时)中,对于在6小时内接受血管内治疗的患者,ASPECTS在结局不良的≤5和>5之间未显示出鉴别差异。
在血管内治疗患者中,尤其是在卒中发作后6小时内,CTP核心≥70 mL定义的大面积核心比ASPECTS≤5定义的核心更能预测不良结局。